Attached files
file | filename |
---|---|
EX-99.1 - HI TECH PHARMACAL CO INC | v205073_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of report (Date of earliest event
reported)
|
December 9,
2010
|
HI-TECH PHARMACAL CO., INC.
|
(Exact Name of Registrant as
Specified in Its
Charter)
|
Delaware
|
(State or Other Jurisdiction
of
Incorporation)
|
No. 0-20424
|
11-2638720
|
(Commission
File Number)
|
(IRS Employer Identification
No.)
|
369 Bayview Avenue, Amityville, New
York
|
11701
|
(Address of Principal
Executive Offices)
|
(Zip
Code)
|
(631) 789-8228
|
(Registrant’s Telephone
Number, Including Area
Code)
|
|
(Former Name or Former
Address, if Changed Since Last
Report)
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction A.2.
below):
o Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR
240.13e-4(c))
Item
2.02.
|
Results
of Operations and Financial
Condition.
|
On December 9, 2010, Hi-Tech Pharmacal
Co., Inc. issued a press release announcing its financial results for the second
fiscal quarter ended October 31, 2010. A copy of the press release is
attached hereto as Exhibit 99.1 to this current report and is incorporated
herein by reference.
Exhibit
9.01.
|
Financial
Statements and Exhibits
|
Exhibit
Number
|
Description
|
Exhibit
99.1
|
Press
Release dated December 9, 2010 of Hi-Tech Pharmacal Co.,
Inc.
|
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: December 9, 2010 | HI-TECH PHARMACAL CO., INC. | ||
|
By:
|
/s/ David S. Seltzer | |
Name: David S. Seltzer | |||
Title: President and Chief Executive Officer | |||
3
INDEX
TO EXHIBITS
Exhibit Number
|
Description
|
99.1
|
Press
Release dated December 9, 2010 of Hi-Tech Pharmacal Co.,
Inc.
|
4